PCR - Private Capital Research Buy Side M&A : Outsourced Private Equity Deal Flow, Outsourced Corporate Development

For private equity professionals and business development groups, PCR is a solution to a basic challenge – staying in the market – when distractions such as tending to the operational and financial needs of existing portfolio companies, executing a transaction, refinancing a current investment, fund-raising, or generally running a business, can take executives and principals away from generating new investment opportunities.

The PCR program is a way for private equity professionals and corporate development officers to see transaction opportunities and enhance their current deal flow. PCR works within agreed-upon investment criteria to generate opportunities to fit that criteria, and that are real transactions worth pursuing. PCR is not focused on any one industry, rather our professionals have experience in many industries, and PCR knows how to profile and generate opportunities in almost any industry. Our network of professional and trusted advisors, coupled with our proprietary search techniques produces the best deal flow in the middle market for our clients.

Working With Clients
Acquisition Criteria
Representative Transactions
Contact Us